Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Virol Methods ; 151(2): 204-210, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18586333

RESUMEN

Peromyscus maniculatus (deer mouse) is the primary reservoir for Sin Nombre virus (SNV). Although the presence of IgG antibodies is often used as a marker of infection, it provides little information on active infections in a population but usually is an indicator of past infections. The presence of IgM antibodies is a much better marker for determining whether active infections are present in a population. A mu-capture SNV-specific IgM enzyme linked immunosorbent assay (ELISA) was developed. From live-trap and release studies a total of 68 rodent sera were studied for the presence of Sin Nombre virus-specific IgG and IgM antibodies. In these studies, IgM responses were detected in a number of animals. In some cases early SNV infection was determined through the presence of anti-SNV IgM before IgG antibodies could be detected. From the set of animals analyzed, it was concluded that the IgM response against SNV can persist anywhere from 1 to up to over 2 months, with a median of less than 1 month. Most importantly, it was demonstrated that anti-Sin Nombre virus IgM is an important tool for detection of early infections in rodents and should be considered as a key diagnostic tool.


Asunto(s)
Inmunoglobulina G/análisis , Inmunoglobulina M/análisis , Peromyscus/inmunología , Peromyscus/virología , Virus Sin Nombre/inmunología , Animales , Anticuerpos Antivirales/análisis , Especificidad de Anticuerpos , Ensayo de Inmunoadsorción Enzimática/métodos , Síndrome Pulmonar por Hantavirus/inmunología , Síndrome Pulmonar por Hantavirus/veterinaria
2.
J Clin Microbiol ; 45(11): 3506-13, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17804663

RESUMEN

Rift Valley fever (RVF) virus is a mosquito-borne virus associated with large-scale epizootics/epidemics throughout Africa and the Arabian peninsula. Virus infection can result in economically disastrous "abortion storms" and high newborn mortality in livestock. Human infections result in a flu-like illness, with 1 to 2% of patients developing severe complications, including encephalitis or hemorrhagic fever with high fatality rates. There is a critical need for a highly sensitive and specific molecular diagnostic assay capable of detecting the natural genetic spectrum of RVF viruses. We report here the establishment of a pan-RVF virus quantitative real-time reverse transcription-PCR assay with high analytical sensitivity (approximately 5 RNA copies of in vitro-transcribed RNA/reaction or approximately 0.1 PFU of infectious virus/reaction) and efficiency (standard curve slope = -3.66). Based on the alignments of the complete genome sequences of 40 ecologically and biologically diverse virus isolates collected over 56 years (1944 to 2000), the primer and probe annealing sites targeted in this assay are known to be located in highly conserved genomic regions. The performance of this assay relative to serologic assays is illustrated by testing of known RVF case materials obtained during the Saudi Arabia outbreak in 2000. Furthermore, analysis of acute-phase blood samples collected from human patients (25 nonfatal, 8 fatal) during that outbreak revealed that patient viremia at time of presentation at hospital may be a useful prognostic tool in determining patient outcome.


Asunto(s)
Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Virus de la Fiebre del Valle del Rift/aislamiento & purificación , Secuencia de Bases , Humanos , Datos de Secuencia Molecular , ARN Viral/análisis , Sensibilidad y Especificidad , Carga Viral
3.
J Virol ; 80(13): 6497-516, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16775337

RESUMEN

In March 2005, the Centers for Disease Control and Prevention (CDC) investigated a large hemorrhagic fever (HF) outbreak in Uige Province in northern Angola, West Africa. In total, 15 initial specimens were sent to CDC, Atlanta, Ga., for testing for viruses associated with viral HFs known to be present in West Africa, including ebolavirus. Marburgvirus was also included despite the fact that the origins of all earlier outbreaks were linked directly to East Africa. Surprisingly, marburgvirus was confirmed (12 of 15 specimens) as the cause of the outbreak. The outbreak likely began in October 2004 and ended in July 2005, and it included 252 cases and 227 (90%) fatalities (report from the Ministry of Health, Republic of Angola, 2005), making it the largest Marburg HF outbreak on record. A real-time quantitative reverse transcription-PCR assay utilized and adapted during the outbreak proved to be highly sensitive and sufficiently robust for field use. Partial marburgvirus RNA sequence analysis revealed up to 21% nucleotide divergence among the previously characterized East African strains, with the most distinct being Ravn from Kenya (1987). The Angolan strain was less different ( approximately 7%) from the main group of East African marburgviruses than one might expect given the large geographic separation. To more precisely analyze the virus genetic differences between outbreaks and among viruses within the Angola outbreak itself, a total of 16 complete virus genomes were determined, including those of the virus isolates Ravn (Kenya, 1987) and 05DRC, 07DRC, and 09DRC (Democratic Republic of Congo, 1998) and the reference Angolan virus isolate (Ang1379v). In addition, complete genome sequences were obtained from RNAs extracted from 10 clinical specimens reflecting various stages of the disease and locations within the Angolan outbreak. While the marburgviruses exhibit high overall genetic diversity (up to 22%), only 6.8% nucleotide difference was found between the West African Angolan viruses and the majority of East African viruses, suggesting that the virus reservoir species in these regions are not substantially distinct. Remarkably few nucleotide differences were found among the Angolan clinical specimens (0 to 0.07%), consistent with an outbreak scenario in which a single (or rare) introduction of virus from the reservoir species into the human population was followed by person-to-person transmission with little accumulation of mutations. This is in contrast to the 1998 to 2000 marburgvirus outbreak, where evidence of several virus genetic lineages (with up to 21% divergence) and multiple virus introductions into the human population was found.


Asunto(s)
Brotes de Enfermedades , Genoma Viral/genética , Enfermedad del Virus de Marburg/genética , Enfermedad del Virus de Marburg/mortalidad , Marburgvirus/genética , Mutación , Angola/epidemiología , Secuencia de Bases , Brotes de Enfermedades/historia , Femenino , Historia del Siglo XXI , Humanos , Kenia/epidemiología , Masculino , Enfermedad del Virus de Marburg/historia , Enfermedad del Virus de Marburg/transmisión , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ARN , Especificidad de la Especie
4.
Emerg Infect Dis ; 10(3): 419-25, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15109407

RESUMEN

Oropharyngeal tularemia was identified as the cause of a die-off in captured wild prairie dogs at a commercial exotic animal facility in Texas. From this point source, Francisella tularensis-infected prairie dogs were traced to animals distributed to the Czech Republic and to a Texas pet shop. F. tularensis culture isolates were recovered tissue specimens from 63 prairie dogs, including one each from the secondary distribution sites. Molecular and biochemical subtyping indicated that all isolates were F. tularensis subsp. holarctica (Type B). Microagglutination assays detected antibodies against F. tularensis, with titers as great as 1:4,096 in some live animals. All seropositive animals remained culture positive, suggesting that prairie dogs may act as chronic carriers of F. tularensis. These findings demonstrate the need for additional studies of tularemia in prairie dogs, given the seriousness of the resulting disease, the fact that prairie dogs are sold commercially as pets, and the risk for pet-to-human transmission.


Asunto(s)
Brotes de Enfermedades/veterinaria , Francisella tularensis/aislamiento & purificación , Sciuridae , Tularemia/veterinaria , Animales , Anticuerpos Antibacterianos/aislamiento & purificación , Técnica del Anticuerpo Fluorescente Directa , Francisella tularensis/clasificación , Francisella tularensis/inmunología , Humanos , Texas/epidemiología , Tularemia/epidemiología , Tularemia/fisiopatología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda